$67.8M Revs; est. $66.3M
$11.3M AEBITDA: est. $10.6M
($6.5M) O/I; est. $5.6m
$27.2M GP; est. $29.6M
40.1% GM; est. 44.6%
($18M) N/I; est. ($11.7M)
*$7.3m goodwill impairment ($8.6m overall impairments)
*$7.9m addback on FV change of derivatives
Call Notes
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.